Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04211116
Other study ID # KDAR FN Brno 2020/1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2020
Est. completion date February 15, 2021

Study information

Verified date February 2021
Source Brno University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Securing the intravenous line is one of the fundamental interventions in paediatric anaesthesia and intensive care. Central venous catheters (CVC) are indicated for long-term stay in intensive care unit (ICU), in case of circulatory instability and the need for vasopressor therapy, for hypertonic solutions administration and parenteral nutrition. The dominant method of CVC insertions is the Seldingers´ method (over the wire) and ultrasound real-time navigation in recommended. Ultrasound-guided (USG) CVC insertion however requires experience personnel and relevant training.This could be the main reason, that CVC the real-time ultrasound navigation is still not adequately implemented into the clinical practice.


Description:

After Ethics committee approval, patients indicated for CVC insertions will be included. Based on the observational design of the trial, the method of insertion (Real-time ultrasound navigation versus anatomical-based CVC insertion) will be based on operators´ decision.The indication for CVC insertion, primary planned site of insertion, USG implementation, site of actual CVC cannulation and associated complications will be recorded. The primary aim of the study was to compare the effectivity of Real-time ultrasound navigation versus anatomical-based CVC insertion in paediatric patients and the 1st percutaneous puncture success rate. The secondary aims will be the incidence of associated complications and the time form first percutaneous puncture, to definitely securing the CVC in place. The primary hypothesis is that the Ultrasound-guided CVC insertion is superior, with the higher overall success, higher first attempt success rate and with lower incidence of associated complications.


Recruitment information / eligibility

Status Completed
Enrollment 107
Est. completion date February 15, 2021
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 19 Years
Eligibility Inclusion Criteria: - Pediatric patients within the age limit indicated for CVC insertion Exclusion Criteria: - Outside the age limit

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Central venous line insertion
Pediatric patients indicated to central venous line insertion

Locations

Country Name City State
Czechia University Hospital Brno Brno State

Sponsors (1)

Lead Sponsor Collaborator
Brno University Hospital

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall success and first attempt success rate The overall success rate and first attempt success rate will be evaluated between ultrasound-guided and anatomical-based navigation During CVC insertion
Secondary Incidence of complications Incidence of arterial puncture, hemothorax and/or pneumothorax incidence, incidence of CVC malposition will be recorded 24 hours from CVC insertion
Secondary Time of insertion The time from first percutaneous puncture to CVC insertion will be monitored and evaluated between During CVC insertion
See also
  Status Clinical Trial Phase
Completed NCT02314520 - Complications Associated With Central Venous Access in the NSICU: PICC vs CVC N/A
Recruiting NCT05415449 - Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study